CGON Latest Press Releases

-- January 14, 2026 --

Oncolytics Biotech Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics Globe Newswire 9:00 AM

-- January 9, 2026 --

CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC Globe Newswire 8:30 AM

-- January 6, 2026 --

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM

-- December 18, 2025 --

SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award Globe Newswire 8:00 AM

-- December 5, 2025 --

New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer Globe Newswire 8:30 AM

-- November 26, 2025 --

CG Oncology Announces New Board Member and Board Transition Globe Newswire 7:00 AM

-- November 25, 2025 --

CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting Globe Newswire 4:05 PM

-- November 14, 2025 --

CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software